Biotech company Moderna has become the first to bring a possible coronavirus vaccine to clinical trials. Dan is joined by Axios health care business reporter Bob Herman to lay out the best case scenario timeline for the company’s vaccine and what makes it different from a typical vaccine. PLUS: Amazon staffs up and old Hollywood turns to streaming.

Biotech company Moderna has become the first to bring a possible coronavirus vaccine to clinical trials. Dan is joined by Axios health care business reporter Bob Herman to lay out the best case scenario timeline for the company’s vaccine and what makes it different from a typical vaccine. PLUS: Amazon staffs up and old Hollywood turns to streaming.

Biotech company Moderna has become the first to bring a possible coronavirus vaccine to clinical trials. Dan is joined by Axios health care business reporter Bob Herman to lay out the best case scenario timeline for the company’s vaccine and what makes it different from a typical vaccine.&nbsp;PLUS: Amazon staffs up and old Hollywood turns to streaming.

The Race for a Cure

Each weekday afternoon, Axios unpacks the biggest story of the day and why it matters. We'll take you inside the accelerating forces, technologies and trends that are remaking your world and work. About Axios: Axios is a digital media company launched in 2017. Axios - which means “worthy” in Greek - helps you become smarter, faster with news and information across politics, tech, business, media, science and the world. Subscribe to our newsletters at axios.com/newsletters and download our mobile app at axios.com/app. 

Axios Re:Cap is on hiatus until October 2021.

News

Daily News

Each weekday afternoon, Axios unpacks the biggest story of the day and why it matters. We'll take you inside the accelerating forces, technologies and trends that are remaking your world and work. About Axios: Axios is a digital media company launched in 2017. Axios - which means “worthy” in Greek - helps you become smarter, faster with news and information across politics, tech, business, media, science and the world. Subscribe to our newsletters at axios.com/newsletters and download our mobile app at axios.com/app. Axios Re:Cap is on hiatus until October 2021.

Each weekday afternoon, Axios unpacks the biggest story of the day and why it matters. We'll take you inside the accelerating forces, technologies and trends that are remaking your world and work. About Axios: Axios is a digital media company launched in 2017. Axios - which means “worthy” in Greek - helps you become smarter, faster with news and information across politics, tech, business, media, science and the world. Subscribe to our newsletters at axios.com/newsletters and download our mobile app at axios.com/app.&nbsp;

Axios Re:Cap is on hiatus until October 2021.

Share The Race for a Cure

Sign up to save your podcasts

The Race for a Cure

The Race for a Cure

More shows like Axios Re:Cap

Freakonomics Radio

Planet Money

Marketplace

Making Sense with Sam Harris

The Daily

Up First from NPR

Today, Explained

Post Reports

The Journal.

Squawk Pod

The Prof G Pod with Scott Galloway

All-In with Chamath, Jason, Sacks & Friedberg

Consider This from NPR

1 big thing

Hard Fork

How It Happened

The Ezra Klein Show